Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children
Clinical trial NCT03826901 · COMPLETED
Trial details
- NCT number
- NCT03826901
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-20
- Primary completion
- 2021-10-29
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.